Vyas Cancer Research Profile
Key Indicators
- Authorised Capital ₹ 20.72 Cr
- Paid Up Capital ₹ 13.63 Cr
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 182.02%
- Profit Growth -1.56%
- Ebitda -0.03%
- Net Worth -10.86%
- Total Assets -6.00%
About Vyas Cancer Research
Vyas Cancer Research Private Limited (VCRPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 07 October 2015 (Nine years and four months 18 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 20.72 Cr and a paid-up capital of Rs 13.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vyas Cancer Research Private Limited India is Rani Rai as COMPANY SECRETARY. Hima Gaddipati, Sambasivarao Gaddipati, and Mandar Kulkarni serve as directors at the Company.
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85191AP2015PTC097487
- Company No.
097487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Vyas Cancer Research?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hima Gaddipati  | Managing Director | 07-Oct-2015 | Current |
Rani Rai  | Company Secretary | 02-Dec-2023 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sambasivarao Gaddipati | Director | 07-Oct-2015 | Current |
| Mandar Kulkarni | Director | 02-Feb-2019 | Current |
Financial Performance of Vyas Cancer Research.
Vyas Cancer Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 182.02% increase. The company also saw a slight decrease in profitability, with a 1.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vyas Cancer Research?
In 2022, Vyas Cancer Research had a promoter holding of 84.15% and a public holding of 15.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skmahi Healthcare Private LimitedHima Gaddipati and Mandar Kulkarni are mutual person
- Innohub Infra Development Private Limited
Hima Gaddipati and Mandar Kulkarni are mutual person
- Eliczen Lifesciences Private Limited
Hima Gaddipati, Sambasivarao Gaddipati and 1 more are mutual person
- Translational Oncology Council
Hima Gaddipati and Mandar Kulkarni are mutual person
- Kkveda Healthcare Private Limited
Hima Gaddipati and Mandar Kulkarni are mutual person
- Innohub Infra Private Limited
Mandar Kulkarni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vyas Cancer Research?
Unlock and access historical data on people associated with Vyas Cancer Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vyas Cancer Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vyas Cancer Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
